Attached files
| file | filename |
|---|---|
| EX-5.1 - EXHIBIT 5.1 - HUMAN GENOME SCIENCES INC | c24334exv5w1.htm |
| EX-4.1 - EXHIBIT 4.1 - HUMAN GENOME SCIENCES INC | c24334exv4w1.htm |
| EX-4.2 - EXHIBIT 4.2 - HUMAN GENOME SCIENCES INC | c24334exv4w2.htm |
| EX-1.1 - EXHIBIT 1.1 - HUMAN GENOME SCIENCES INC | c24334exv1w1.htm |
| 8-K - FORM 8-K - HUMAN GENOME SCIENCES INC | c24334e8vk.htm |
Exhibit 99.1
Information Relating to Part II, Item 14 — Other Expenses of Issuance and Distribution
The expenses in connection with the offering of $494.5 million aggregate principal amount of
3.00% Convertible Senior Notes due 2018 by Human Genome Science, Inc., registered pursuant to a
Registration Statement on Form S-3 (Registration No. 333-162731) filed on October 29, 2009, are set
forth in the following table. All amounts are estimated except the Securities and Exchange
Commission registration fee.
Securities and Exchange Commission Registration Fee |
$ | 56,670 | ||
Accounting Fees and Expenses |
174,000 | |||
Legal Fees and Expenses |
250,000 | |||
Printing Expenses |
25,000 | |||
Fees and Expenses of Trustee |
6,000 | |||
Miscellaneous Expenses |
10,000 | |||
Total |
$ | 521,670 | ||